Financials
| Posting of 2024 Annual Report and Notice of AGM | May. 06, 2025 |
| Final results for 2024 | Apr. 22, 2025 |
| Arecor Full Year 2024 Trading Update | Feb. 03, 2025 |
| Interim Results for six months ended 30 June 2024 | Sep. 26, 2024 |
| Trading and Funding Update | Jun. 10, 2024 |
| Final results for 2023 | May. 16, 2024 |
| Year End Trading Update | Feb. 01, 2024 |
Proxies
| Result of AGM | Jun. 02, 2025 |
| Result of General Meeting and Total Voting Rights | Aug. 08, 2024 |
| Result of AGM | Jun. 28, 2024 |
| Posting of 2023 Annual Report and Notice of AGM | May. 31, 2024 |
| Result of AGM | Jun. 09, 2023 |
| AGM Statement | Jun. 09, 2023 |
| RESULT OF AGM | May. 23, 2022 |
Ownership Update
| Grant of Options and PDMR Dealing | Jun. 04, 2025 |
| Director/PDMR Dealing | May. 21, 2025 |
| Director Dealing | May. 14, 2025 |
| Grant of Options and PDMR Dealing | Apr. 23, 2025 |
| Grant of Options and PDMR Dealing | Dec. 02, 2024 |
| Holding(s) in Company | Aug. 22, 2024 |
| Holding(s) in Company | Aug. 12, 2024 |
Announcements
| Arecor Establishes New Scientific Advisory Board | Jul. 14, 2025 |
| Non-Executive Director Board Change | Jun. 02, 2025 |
| Arecor Partnership with Skye Bioscience | May. 19, 2025 |
| Arecor sells rights to non-Ogluo® products | May. 08, 2025 |
| Arecor to present on Investor Meet Company | Apr. 24, 2025 |
| Notice of Results | Apr. 10, 2025 |
| Collaboration with global pharmaceutical partner | Mar. 26, 2025 |